Review INTAS PHARMA || USFDA 483 Observations ||May 2023 ||

[@RAMKUMAR-fb7gt]

Thanks for sharing

[@ramakrishnaguttula7941]

Thanks for sharing sir

[@PharmaPill]

Welcome!

[@pharmasolutionpakistan7668]

Good mashallah

[@manojmodi414]

Thank you very much Sir

[@RajRaj-mr3pr]

Can You Please Share a Link to Download This.

[@patelvishal2313]

Make video USFDA 483 Zydus Jarod facility currently conducted audit

[@aaaa-dr2oz]

Please update 2024 years 483 observations

[@rupchandpitekar2747]

@pharma pill can you make telegram group to share any documents or information?

[@maheshpds9]

What are the new updates in usfda OOS guidelines?

[@sameer_shindeshinde3674]

Why they not manage USFDA auditors...

[@PharmaPill]

it’s difficult to manage 3 auditors at a time…

[@narendraykhambe7489]

Now a day its very difficult.

[@rupchandpitekar2747]

Auditors now directly communicate to doers and this is a surprise audit, management doesn't have authority to enter without auditors permission in the inspection area.😊